Bioextrax AB (publ)

DB:85X0 Stock Report

Market Cap: €8.7m

Bioextrax Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Edvard Hall

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2yrs
CEO ownershipn/a
Management average tenure2yrs
Board average tenure2.8yrs

Recent management updates

Recent updates

CEO

Edvard Hall (39 yo)

2yrs

Tenure

Mr. Edvard Hall serves as Chief Executive Officer at Bioextrax AB (publ) since 2023. He served as Director Business Development at Bioextrax AB (publ) since May 2022 until January 2023 and was its Chief Ex...

Leadership Team

NamePositionTenureCompensationOwnership
Edvard Hall
Chief Executive Officer2yrsno datano data
Mohammad H. Ibrahim
Founder & Advisorno datano data5.59%
€ 487.7k
Kristofer Svensson
Chief Financial Officer2yrsno datano data
Klas Ingstorp
Chief Operating Officer3yrsno datano data
Kristofer Cook
Business Development Managerno datano datano data

2.0yrs

Average Tenure

47yo

Average Age

Experienced Management: 85X0's management team is considered experienced (2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Mohammad H. Ibrahim
Founder & Advisorless than a yearno data5.59%
€ 487.7k
Fredrik Sjodin
Director3.6yrsno datano data
Alexander Steinbüchel
Member of Advisory Boardno datano datano data
Per Hokfelt
Director2.8yrsno datano data
Håkan Björnberg
Directorno datano datano data
Marie Gronborg
Directorno datano datano data
Mats Persson
Chairman of the Board2.8yrsno datano data
Kjell Bache
Member of Advisory Boardno datano datano data
Yossi Shabtai
Member of Advisory Boardno datano datano data
Nicolas Nouvel
Member of Advisory Board3.8yrsno datano data
Jan Ravenstijn
Member of Advisory Board2.9yrsno datano data

2.8yrs

Average Tenure

56yo

Average Age

Experienced Board: 85X0's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/12 23:46
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bioextrax AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution